Patent No. EP3763384 (titled "Pharmaceutical Product With Increased Stability Comprising Immunoglobulins") was filed by CSL Behring on Dec 3, 2015. The application was issued on Aug 28, 2024.

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
| Company | Opposition Date | Representative |
|---|---|---|
| OCTAPHARMA | May 28, 2025 | ULLRICH & NAUMANN PARTG MBB |
The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents
Oct 15, 2025
Oct 15, 2025
Oct 15, 2025
Oct 15, 2025
Oct 14, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 10, 2025
Oct 9, 2025
Oct 9, 2025
Oct 9, 2025
Jun 11, 2025
Jun 11, 2025
Jun 4, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
May 28, 2025
Sep 10, 2024
Aug 1, 2024
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
Jul 23, 2024
Jul 1, 2024
Jul 1, 2024
Jul 1, 2024
Jul 1, 2024
Jul 1, 2024
Jul 1, 2024
Apr 9, 2024
Apr 9, 2024
Apr 9, 2024
Apr 9, 2024
Apr 9, 2024
Mar 18, 2024
Mar 18, 2024
Jan 16, 2024
Jan 16, 2024
Jan 16, 2024
Jan 16, 2024
Jan 16, 2024
Jan 16, 2024
Jan 16, 2024
Dec 21, 2023
Dec 21, 2023
Nov 9, 2023
Nov 9, 2023
Nov 9, 2023
Nov 9, 2023
Nov 9, 2023
Nov 9, 2023
Nov 9, 2023
Oct 18, 2023
Oct 18, 2023
Aug 16, 2023
Aug 16, 2023
Aug 16, 2023
Aug 16, 2023
Aug 16, 2023
Aug 16, 2023
Aug 16, 2023
Jun 13, 2023
Jun 13, 2023
Jun 7, 2023
Jun 3, 2022
May 31, 2022
May 31, 2022
Dec 1, 2021
Aug 12, 2021
Aug 6, 2021
Aug 6, 2021
Jun 30, 2021
Jun 30, 2021
Jun 30, 2021
Jun 30, 2021
Jun 30, 2021
Jan 18, 2021
Dec 16, 2020
Dec 9, 2020
Dec 4, 2020
Dec 4, 2020
Dec 4, 2020
Dec 4, 2020
Nov 30, 2020
Nov 23, 2020
Nov 23, 2020
Nov 23, 2020
Nov 12, 2020
Nov 5, 2020
Oct 9, 2020
Oct 9, 2020
Sep 7, 2020
Jul 24, 2020
Jul 21, 2020
Jul 21, 2020
Jul 21, 2020
Jul 16, 2020
Jul 16, 2020
Jul 16, 2020
Jul 16, 2020
Jul 16, 2020
Jul 16, 2020
Jul 16, 2020
Jun 28, 2016